Variant report
Variant | esv3495171 |
---|---|
Chromosome Location | chr4:16443327-16445273 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186435047 | chr4:16443338-16443339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs575873809 | chr4:16443345-16443346 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544956119 | chr4:16443359-16443360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191987748 | chr4:16443367-16443368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs371055809 | chr4:16443452-16443453 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs201162794 | chr4:16443460-16443461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149086150 | chr4:16443464-16443465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs199855145 | chr4:16443465-16443466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs33983809 | chr4:16443466-16443467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143109570 | chr4:16443467-16443468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs34857676 | chr4:16443486-16443487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs199806369 | chr4:16443487-16443488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs398063316 | chr4:16443498-16443499 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs183469129 | chr4:16443500-16443501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs76769444 | chr4:16443502-16443503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188450819 | chr4:16443504-16443505 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs199905180 | chr4:16443507-16443508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112065621 | chr4:16443509-16443510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192840735 | chr4:16443528-16443529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562567518 | chr4:16443540-16443541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563294083 | chr4:16443574-16443575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs145454160 | chr4:16443575-16443576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551225934 | chr4:16443622-16443623 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs182919578 | chr4:16443641-16443642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115963680 | chr4:16443647-16443648 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34473162 | chr4:16443654-16443655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74511755 | chr4:16443672-16443673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567346205 | chr4:16443675-16443676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs535992025 | chr4:16443721-16443722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs555913388 | chr4:16443843-16443844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187110647 | chr4:16443851-16443852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs538465030 | chr4:16443864-16443865 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs558448291 | chr4:16443866-16443867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530719746 | chr4:16443900-16443901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4698148 | chr4:16443928-16443929 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs373240198 | chr4:16443956-16443957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs75404600 | chr4:16443978-16443979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs553927125 | chr4:16443979-16443980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574054411 | chr4:16444008-16444009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533202797 | chr4:16444021-16444022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs542785858 | chr4:16444105-16444106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs563013536 | chr4:16444136-16444137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs531373401 | chr4:16444240-16444241 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs73798771 | chr4:16444272-16444273 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs73798772 | chr4:16444303-16444304 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs527620739 | chr4:16444305-16444306 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs145044260 | chr4:16444339-16444340 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs116215980 | chr4:16444357-16444358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs529708863 | chr4:16444386-16444387 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1158866 | chr4:16444413-16444414 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Breast cancer | 21509527 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:16441000-16443800 | Enhancers | Fetal Brain Male | brain |
2 | chr4:16443800-16449600 | Weak transcription | Fetal Brain Male | brain |
3 | chr4:16444200-16444400 | Enhancers | NH-A | brain |